Humana Inc. Files Form 8-K

Ticker: HUM · Form: 8-K · Filed: 2025-12-01T00:00:00.000Z

Sentiment: neutral

Topics: corporate-update, regulation-fd

Related Tickers: HUM

TL;DR

Humana filed an 8-K on Dec 1, 2025, updating corporate info. Standard stuff.

AI Summary

Humana Inc. filed a Form 8-K on December 1, 2025, reporting information under Regulation FD. The filing details the company's principal executive offices located at 500 West Main Street, Louisville, Kentucky, 40202, and its telephone number as (502) 580-1000. This report serves as a current update for the company.

Why It Matters

This filing indicates Humana Inc. is providing an update on its corporate information, which is standard procedure for publicly traded companies to maintain transparency with investors.

Risk Assessment

Risk Level: low — This filing is a routine corporate update and does not contain information that suggests a significant change in risk for the company.

Key Players & Entities

FAQ

What is the primary purpose of this Form 8-K filing for Humana Inc.?

The primary purpose of this Form 8-K filing is to report information under Regulation FD and to provide a current update on the company's corporate details.

When was this Form 8-K filed by Humana Inc.?

This Form 8-K was filed on December 1, 2025.

What is Humana Inc.'s principal executive office address?

Humana Inc.'s principal executive office is located at 500 West Main Street, Louisville, Kentucky, 40202.

What is the telephone number for Humana Inc.'s principal executive offices?

The telephone number for Humana Inc.'s principal executive offices is (502) 580-1000.

Under which section of the Securities Exchange Act is this Form 8-K filed?

This Form 8-K is filed pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934.

From the Filing

0000049071-25-000059.txt : 20251201 0000049071-25-000059.hdr.sgml : 20251201 20251201073038 ACCESSION NUMBER: 0000049071-25-000059 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20251201 ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20251201 DATE AS OF CHANGE: 20251201 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HUMANA INC CENTRAL INDEX KEY: 0000049071 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance EIN: 610647538 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-05975 FILM NUMBER: 251537141 BUSINESS ADDRESS: STREET 1: 500 W MAIN ST CITY: LOUISVILLE STATE: KY ZIP: 40202 BUSINESS PHONE: 5025801000 MAIL ADDRESS: STREET 1: 500 W. MAIN ST CITY: LOUISVILLE STATE: KY ZIP: 40202 FORMER COMPANY: FORMER CONFORMED NAME: EXTENDICARE INC DATE OF NAME CHANGE: 19740404 FORMER COMPANY: FORMER CONFORMED NAME: HERITAGE HOUSE OF AMERICA INC DATE OF NAME CHANGE: 19671129 8-K 1 hum-20251201.htm 8-K hum-20251201 0000049071 false 0000049071 2025-12-01 2025-12-01 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 1, 2025 ( December 1, 2025 ) Humana Inc. (Exact name of registrant as specified in its charter) Delaware 001-5975 61-0647538 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 500 West Main Street , Louisville , Kentucky 40202 (Address of principal executive offices, including zip code) ( 502 ) 580-1000 (Registrant’s telephone number, including area code) (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock HUM New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company   ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐ Item 7.01. Regulation FD Disclosure. Members of Humana Inc.’s (the “Company”) senior management team are scheduled to meet with investors and analysts at various meetings between December 1, 2025 and December 31, 2025. During these meetings, the Company intends to reaffirm its guidance of approximately $12.26 in diluted earnings per common share (“EPS”) or approximately $17.00 in adjusted earnings per common share (“Adjusted EPS”), in each case for the year ending December 31, 2025 (“FY 2025”). This guidance is consistent with the guidance issued in the Company’s press release dated November 5, 2025. The Company has included Adjusted EPS in this current report, a financial measure that is not in accordance with Generally Acc

View on Read The Filing